{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Annual drug update: 2011 in review

Activity Steps

Purpose of Activity

To provide the NP with an overview of seven new medications approved in 2011.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Explain the indications, mechanism of action, and pharmacokinetics of the new drugs.
  2. Describe the dosing and administration of these new medications.
  3. Illustrate the contraindications and precautions, adverse reactions, and important clinical considerations when prescribing these new medications.
Price: $24.95

Credits:

  • ANCC 2.9 CH / 2.9 APH
  • DC - BON 2.9 CH
  • DC - BON 2.9 CH
  • KY-BON 2.9 CH
  • KY-BON 2.9 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
--------------------------------------------------
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #50-1223. Your certificate is valid in all states.
--------------------------------------------------
The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.

Awarded Advanced Pharmacology Hours.









Test Code: NP0212A
Published: February 2012
Expires: 12/31/2026
Required Passing Score: 12/17 (70%)
Authors: Jennifer M. Belavic PharmD, BCPS, FASCP
Topics: Dialysis